Neurocrine Biosciences, Inc. (NBIX)
153.04
+0.47
(+0.31%)
USD |
NASDAQ |
Aug 24, 16:00
153.04
0.00 (0.00%)
After-Hours: 18:24
Neurocrine Biosciences Price : 153.04 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 153.13 | 155.26 | 152.51 | 152.57 | 1.228M |
| Aug 20, 2026 | 154.99 | 155.81 | 152.50 | 152.93 | 870659.0 |
| Aug 19, 2026 | 156.56 | 156.56 | 154.34 | 155.54 | 1.163M |
| Aug 18, 2026 | 155.92 | 156.24 | 153.46 | 154.23 | 1.038M |
| Aug 17, 2026 | 151.62 | 154.81 | 150.69 | 154.49 | 1.169M |
| Aug 14, 2026 | 149.72 | 153.42 | 148.78 | 152.72 | 1.305M |
| Aug 13, 2026 | 154.43 | 155.81 | 150.20 | 150.82 | 2.056M |
| Aug 12, 2026 | 159.74 | 159.98 | 154.86 | 156.49 | 2.094M |
| Aug 11, 2026 | 165.46 | 165.46 | 161.78 | 161.94 | 808120.0 |
| Aug 10, 2026 | 161.52 | 165.15 | 161.52 | 164.92 | 935227.0 |
| Aug 07, 2026 | 161.53 | 164.76 | 159.68 | 163.41 | 971006.0 |
| Aug 06, 2026 | 161.28 | 162.51 | 158.48 | 159.82 | 1.366M |
| Aug 05, 2026 | 168.55 | 168.55 | 161.30 | 161.50 | 1.292M |
| Aug 04, 2026 | 166.89 | 169.02 | 165.70 | 166.06 | 1.197M |
| Aug 03, 2026 | 166.25 | 170.88 | 164.01 | 166.23 | 1.516M |
| Jul 31, 2026 | 184.34 | 185.55 | 164.56 | 166.80 | 4.584M |
| Jul 30, 2026 | 179.00 | 186.12 | 176.60 | 185.50 | 2.172M |
| Jul 29, 2026 | 182.00 | 183.50 | 180.00 | 180.79 | 1.072M |
| Jul 28, 2026 | 178.84 | 182.91 | 176.25 | 182.83 | 1.334M |
| Jul 27, 2026 | 176.46 | 179.15 | 176.00 | 176.41 | 1.048M |
| Jul 24, 2026 | 174.25 | 177.30 | 173.43 | 175.77 | 1.130M |
| Jul 23, 2026 | 170.67 | 174.99 | 170.00 | 174.15 | 1.103M |
| Jul 22, 2026 | 178.87 | 181.00 | 171.81 | 172.69 | 1.192M |
| Jul 21, 2026 | 174.77 | 179.05 | 174.10 | 179.05 | 1.305M |
| Jul 20, 2026 | 172.37 | 174.59 | 171.70 | 173.00 | 977545.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amarin Corp. Plc | 13.82 |
| Liquidia Corp. | 70.28 |
| Incyte Corp. | 127.99 |
| Krystal Biotech, Inc. | 341.78 |
| Halozyme Therapeutics, Inc. | 108.64 |
Price Related Metrics
| PE Ratio | 22.42 |
| PS Ratio | 4.693 |
| PEG Ratio | 0.2210 |
| Price to Book Value | 4.210 |
| Price to Free Cash Flow | 19.50 |
| Earnings Yield | 4.46% |
| Market Cap | 15.55B |
| PEGY Ratio | 0.2210 |
| Operating PE Ratio | 19.64 |
| Normalized PE Ratio | 22.88 |